We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

37 hedge funds and large institutions have $10.1M invested in Assembly Biosciences in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.49% less ownership

Funds ownership: 2.42% → 1.93% (-0.49%)

5% less funds holding

Funds holding: 39 → 37 (-2)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

44% less capital invested

Capital invested by funds: $18M → $10.1M (-$7.91M)

53% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 15

Holders
37
Holders Change
-2
Holders Change %
-5.13%
% of All Funds
0.59%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
7
Reduced
15
Closed
5
Calls
$53K
Puts
–
Net Calls
+$53K
Net Calls Change
+$28K

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$369K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$114K
3
Two Sigma Investments
Two Sigma Investments
New York
+$53.8K
4
Citadel Advisors
Citadel Advisors
Florida
+$45.3K
5
Morgan Stanley
Morgan Stanley
New York
+$18.3K

Top Sellers

1
DTC
Deep Track Capital
Connecticut
-$2.38M
2
PIM
Platinum Investment Management
Australia
-$287K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$140K
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$105K
5
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$85K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.91M +$114K +6,733 +4%
AIM
2
Alerce Investment Management
Illinois
$1.87M – – –
Millennium Management
3
Millennium Management
New York
$1.22M -$67K -3,969 -3%
BlackRock
4
BlackRock
New York
$913K -$68.2K -4,045 -4%
Hudson Bay Capital Management
5
Hudson Bay Capital Management
Connecticut
$798K -$105K -6,250 -7%
PIM
6
Platinum Investment Management
Australia
$749K -$287K -17,003 -19%
Renaissance Technologies
7
Renaissance Technologies
New York
$644K +$369K +21,868 +52%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$380K – – –
Federated Hermes
9
Federated Hermes
Pennsylvania
$305K -$14.9K -884 -3%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$239K -$54.1K -3,209 -12%
BCM
11
Bridgeway Capital Management
Texas
$146K -$20K -1,183 -8%
Fidelity Investments
12
Fidelity Investments
Massachusetts
$133K +$15.8K +936 +8%
Acadian Asset Management
13
Acadian Asset Management
Massachusetts
$132K -$140K -8,296 -39%
State Street
14
State Street
Massachusetts
$122K – – –
Citadel Advisors
15
Citadel Advisors
Florida
$118K +$45.3K +2,683 +30%
Northern Trust
16
Northern Trust
Illinois
$82.7K +$9.73K +577 +8%
Franklin Resources
17
Franklin Resources
California
$69.5K – – –
Morgan Stanley
18
Morgan Stanley
New York
$37.3K +$18.3K +1,087 +42%
Two Sigma Investments
19
Two Sigma Investments
New York
$32.2K +$53.8K +3,192 New
Barclays
20
Barclays
United Kingdom
$30.2K – – –
Two Sigma Advisers
21
Two Sigma Advisers
New York
$27.8K -$6.06K -359 -12%
Charles Schwab
22
Charles Schwab
California
$27.3K – – –
TRCT
23
Tower Research Capital (TRC)
New York
$26K -$28.2K -1,671 -39%
Jane Street
24
Jane Street
New York
$20.4K -$74K -4,388 -68%
Susquehanna International Group
25
Susquehanna International Group
Pennsylvania
$14.4K -$5.74K -340 -19%
1
2

ASMB Hedge Fund Activity: Q1 2023 in Review

37 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q1 2023, worth a combined $10.1M — down 44% from $18M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ASMB and 3 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 7 added.

The largest buyer was Renaissance Technologies, adding an estimated $369K. The largest seller was Deep Track Capital, exiting entirely with an estimated $2.38M sold.

  • 37 institutional investors held Assembly Biosciences (ASMB) as of Q1 2023, down from 39 in Q4 2022.
  • Funds reported $10.1M of Assembly Biosciences stock for Q1 2023, down 44% quarter-over-quarter.
  • 3 funds opened new Assembly Biosciences positions in Q1 2023 and 5 closed out, a net change of -2 holders.
  • The largest Assembly Biosciences buyer in Q1 2023 was Renaissance Technologies, an estimated $369K added.
  • The largest Assembly Biosciences seller in Q1 2023 was Deep Track Capital, an estimated $2.38M sold.

Based on aggregated 13F filings for Q1 2023.